We strategically identify key anti-cancer targets to rejuvenate adaptive and innate immune cells, and to normalize the tumor microenvironment. Based on these targets, we creatively develop novel therapeutic molecules to fight cancer. Cancer cells cunningly evade the immune system using many different mechanisms. We believe that only when the full potential of human immune system is unleashed by precise combinations of therapeutics, cancer can be effectively treated or even cured.